Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (12 ops.)
Latest filing published 14 Jun 2024 for Biocryst Pharmaceuticals INC.
Filing timeline
BuySaleGeorge B. Abercrombie
Insider track record
Disclosed buys
2
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
George B. Abercrombie: trading record in brief
George B. Abercrombie is a declared insider at 4 companies (senior executive); the most frequent names are Biocryst Pharmaceuticals Inc, Innoviva, Inc. and Inspire Pharmaceuticals Inc. The record holds 47 filings, for trades running from 5 April 2010 to 12 June 2024.
The open-market side counts 2 purchases for €17k alongside 12 sales for €1.8M. Taken together, the sales exceed the purchases by €1.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 21 share grants and 11 option exercises.
On 14 June 2024 came the latest disclosure, a share grant in Biocryst Pharmaceuticals Inc. The last purchase on record was published on 13 November 2013, which is 4,727 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to George B. Abercrombie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
6,820 shares0Common StockSEC:0001127602-24-018705:0
16,745 shares0Common StockSEC:0001127602-23-018765:0
12,866 shares0Common StockSEC:0001127602-22-017153:0
5,000 shares@ US$3.320.0009% mcap5.0% of flowCommon StockSEC:0001127602-22-012272:0
5,000 shares@ US$3.320.0009% mcap4.7% of flowCommon StockSEC:0001127602-22-005295:0
5,000 shares@ US$3.328.5% of flowCommon StockSEC:0001127602-21-029440:0
5,000 shares@ US$2.636.5% of flowCommon StockSEC:0001127602-21-025496:0
11,000 shares@ US$1.719.3% of flowCommon StockSEC:0001127602-21-025252:0
5,000 shares@ US$2.636.5% of flowCommon StockSEC:0001127602-21-022226:0
6,667 shares@ US$2.638.4% of flowCommon StockSEC:0001127602-21-018061:0
7,000 shares@ US$12.7043.0% of flowCommon StockSEC:0001127602-21-016433:0
92,587 sharesCommon StockSEC:0001179110-16-017814:0
12 of 12 declarations
